The median net launch price of newly approved U.S. prescription drugs rose 35% after adjusting for inflation, increasing from $190,000 in 2022 to $257,000 in 2025, according to a report by ICER and West Health.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Drug pricing policy, insurance prior authorization, and essential drug shortages affecting medication affordability and access.